John Paul Waymack

Medical Consultant at Marillion Pharmaceuticals, Inc.

John Paul Waymack

John Paul Waymack

Medical Consultant at Marillion Pharmaceuticals, Inc.

Biography

Founder of Kitov Pharma Ltd., John Paul Waymack is former Chief Medical Officer at this company and former Associate Professor at The University of Texas.

Overview
Career Highlights

Purple Biotech Ltd.

RelSci Relationships

48

Number of Boards

2

Birthday

1954

Age

67

Relationships
RelSci Relationships are individuals John Paul Waymack likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Financial Officer & Director at Purple Biotech Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Director at Purple Biotech Ltd.

Relationship likelihood: Strong

Managing Partner at Ourcrowd Pandemic Innovation Fund at OurCrowd Management Ltd.

Relationship likelihood: Strong

Chief Financial Officer at Glide Talk Ltd.

Relationship likelihood: Strong

Former Chief Executive Officer at Meytav Technological Enterprises Innovation Center Ltd.

Relationship likelihood: Strong

Deputy Chief Executive Officer & Chief Financial Officer at Purple Biotech Ltd.

Relationship likelihood: Strong

Chief Medical Officer-New Products at Moleculin Biotech, Inc.

Relationship likelihood: Strong

Co-Founder at Reata Pharmaceuticals, Inc.

Relationship likelihood: Strong

Head, Cutaneous T-Cell Lymphoma & Dermatology at University of Texas - MD Anderson Cancer Center

Relationship likelihood: Strong

Chief Executive Officer at BioLineRX Ltd.

Relationship likelihood: Strong

Paths to John Paul Waymack
Potential Connections via
Relationship Science
You
John Paul Waymack
Medical Consultant at Marillion Pharmaceuticals, Inc.
Career History
Medical Consultant
Current

Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA.

Founder & Chief Medical Officer
1968 - 2020

Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Tel Aviv, Israel.

Associate Professor
Prior

The University of Texas at Austin is one of the largest public universities in the United States and is the largest institution of The University of Texas System. Founded in 1883, the university has grown from a single building, eight teachers, two departments and 221 students to a 350-acre main campus with 17 colleges and schools, about 24,000 faculty and staff, and more than 50,000 students.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Paul Waymack. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Paul Waymack's profile does not indicate a business or promotional relationship of any kind between RelSci and John Paul Waymack.